WallStreetZenWallStreetZen

NASDAQ: PGEN
Precigen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for PGEN

Based on 2 analysts offering 12 month price targets for Precigen Inc.
Min Forecast
$6.00+341.18%
Avg Forecast
$10.00+635.29%
Max Forecast
$14.00+929.41%

Should I buy or sell PGEN stock?

Based on 2 analysts offering ratings for Precigen Inc.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PGEN stock forecasts and price targets.

PGEN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-20
lockedlocked$00.00+00.00%2024-03-20

1 of 1

Forecast return on equity

Is PGEN forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.86%

Forecast return on assets

Is PGEN forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

PGEN revenue forecast

What is PGEN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$6.2M-0.96%
Avg 2 year Forecast
$40.5M+550.12%
Avg 3 year Forecast
$215.7M+3,365.06%
PGEN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PGEN revenue growth forecast

How is PGEN forecast to perform vs Biotechnology companies and vs the US market?
Company
198.74%
Industry
38.34%
Market
10.3%
PGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PGEN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PGEN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PGEN$1.36$10.00+635.29%Buy
AVXL$4.12$40.00+870.87%Buy
RVNC$3.81$13.43+252.47%Buy
TCRX$7.13$11.00+54.28%Strong Buy
RANI$6.87$9.67+40.71%Strong Buy
View Top Biotech Stocks

Precigen Stock Forecast FAQ

Is Precigen Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: PGEN) stock is to Buy PGEN stock.

Out of 2 analysts, 0 (0%) are recommending PGEN as a Strong Buy, 2 (100%) are recommending PGEN as a Buy, 0 (0%) are recommending PGEN as a Hold, 0 (0%) are recommending PGEN as a Sell, and 0 (0%) are recommending PGEN as a Strong Sell.

If you're new to stock investing, here's how to buy Precigen stock.

What is PGEN's revenue growth forecast for 2024-2026?

(NASDAQ: PGEN) Precigen's forecast annual revenue growth rate of 198.74% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.3%.

Precigen's revenue in 2024 is $6,225,000.On average, 2 Wall Street analysts forecast PGEN's revenue for 2024 to be $1,534,586,227, with the lowest PGEN revenue forecast at $1,493,514,576, and the highest PGEN revenue forecast at $1,575,657,878. On average, 3 Wall Street analysts forecast PGEN's revenue for 2025 to be $10,073,755,815, with the lowest PGEN revenue forecast at $1,620,463,315, and the highest PGEN revenue forecast at $26,111,613,170.

In 2026, PGEN is forecast to generate $53,691,849,007 in revenue, with the lowest revenue forecast at $53,691,849,007 and the highest revenue forecast at $53,691,849,007.

What is PGEN's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: PGEN) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is PGEN's Price Target?

According to 2 Wall Street analysts that have issued a 1 year PGEN price target, the average PGEN price target is $10.00, with the highest PGEN stock price forecast at $14.00 and the lowest PGEN stock price forecast at $6.00.

On average, Wall Street analysts predict that Precigen's share price could reach $10.00 by Mar 20, 2025. The average Precigen stock price prediction forecasts a potential upside of 635.29% from the current PGEN share price of $1.36.

What is PGEN's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: PGEN) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.